FY26 126212 - campus compressed gas security
Active Awarded Last action
- Contract number
- 75N91026F00008
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,446,242
Award facts
- Contract value 100% obligated
- $1,446,242.00 Current and potential, with all options
- Completion date 28% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a delivery order contract valued at $1.44M to Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) subsidiary of Leidos Holdings, Inc., for Campus Compressed Gas Security services at the Frederick National Laboratory for Cancer Research in Frederick, Maryland. The contract, which operates under a cost-plus-fixed-fee pricing model with no set-aside designation, has an ultimate completion date of January 19, 2028, and was awarded on April 30, 2026. This delivery order represents continued support for NCI's research infrastructure and operational security requirements at its primary Frederick campus facility.
Leidos Biomedical Research Inc. serves as a critical operational support provider to the National Cancer Institute and broader National Institutes of Health mission, delivering comprehensive facilities management, infrastructure security, and scientific support services to enable the agency's biomedical research portfolio. As an FFRDC contractor, the company has established extensive experience managing multi-year, cost-reimbursable contracts supporting federal research operations, with this compressed gas security contract addressing essential facility safety and operational requirements necessary for the NCI's advanced laboratory and clinical research programs at its Frederick location.
Quick answers
Who was awarded contract 75N91026F00008?
75N91026F00008 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on April 30, 2026.
How much is contract 75N91026F00008 worth?
The government has obligated $1,446,242 on 75N91026F00008.
Is contract 75N91026F00008 an order under another contract?
Yes. 75N91026F00008 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91026F00008 competed?
The extent of competition for 75N91026F00008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award